Ulcerative Colitis: Current and Emerging Treatment Strategies
- PMID: 31905945
- PMCID: PMC7019865
- DOI: 10.3390/jcm9010094
Ulcerative Colitis: Current and Emerging Treatment Strategies
Abstract
Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1-2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the current and emerging treatment strategies for UC stratified according to disease severity.
Keywords: biologic; colectomy; small molecule; ulcerative colitis.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.-F., Gasche C., Geboes K., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005;19(Suppl. A):5a–36a. doi: 10.1155/2005/269076. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
